Y-Intercept (HK)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,760
| Closed | -$566K | – | 1686 |
|
2025
Q1 | $566K | Buy |
+3,760
| New | +$566K | 0.04% | 645 |
|
2023
Q3 | – | Sell |
-10,712
| Closed | -$2.25M | – | 1136 |
|
2023
Q2 | $2.25M | Buy |
10,712
+8,293
| +343% | +$1.74M | 0.24% | 94 |
|
2023
Q1 | $488K | Buy |
+2,419
| New | +$488K | 0.06% | 544 |
|
2022
Q3 | – | Sell |
-5,558
| Closed | -$1.19M | – | 1017 |
|
2022
Q2 | $1.19M | Buy |
5,558
+4,727
| +569% | +$1.01M | 0.16% | 187 |
|
2022
Q1 | $236K | Buy |
+831
| New | +$236K | 0.05% | 547 |
|